IM Cannabis (IMCC) EBIT (2019 - 2025)
Historic EBIT for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $2.8 million.
- IM Cannabis' EBIT rose 45399.35% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 7285478.39%. This contributed to the annual value of $7.5 billion for FY2024, which is 9870512.17% up from last year.
- Per IM Cannabis' latest filing, its EBIT stood at $2.8 million for Q3 2025, which was up 45399.35% from -$140012.2 recorded in Q2 2025.
- IM Cannabis' 5-year EBIT high stood at $9.3 billion for Q4 2021, and its period low was -$98.3 million during Q3 2022.
- Moreover, its 5-year median value for EBIT was -$1.6 million (2023), whereas its average is $867.5 million.
- Per our database at Business Quant, IM Cannabis' EBIT tumbled by 208726.42% in 2022 and then skyrocketed by 28373468.33% in 2024.
- Quarter analysis of 5 years shows IM Cannabis' EBIT stood at $9.3 billion in 2021, then plummeted by 100.26% to -$24.6 million in 2022, then soared by 89.51% to -$2.6 million in 2023, then soared by 283734.68% to $7.3 billion in 2024, then crashed by 99.96% to $2.8 million in 2025.
- Its last three reported values are $2.8 million in Q3 2025, -$140012.2 for Q2 2025, and $110112.8 during Q1 2025.